Complete Genomics Launches, Becomes World's First Large-Scale Human Genome Sequenci...(. Our customers will conduct these stud...)

Date:10/6/2008

. "Our customers will conduct these studies to reveal the genetic basis of all major human diseases including cancer, psychiatric and neurological diseases, metabolic and cardiovascular diseases, autoimmune diseases, and many other poorly understood multifactorial diseases."

Data Center

A key component of Complete Genomics' sequencing center is its data center, purpose-built to manage and analyze the staggering amount of genetic data that will be generated by sequencing thousands of human genomes. Because the data generated by a single human genome would fill 1,000 laptop computers, each with 100 GB of disk storage, data management for Complete Genomics' genome center will be a massive undertaking. The company plans to have 10,000 processors with five petabytes (5 million gigabytes) of disk storage in 2009 and will further increase its capacity to 60,000 processors with 30 petabytes of disk storage in 2010. Complete Genomics expects to sequence 200 genomes per day by the end of 2010, making it the world's highest-throughput human genome sequencing center. To put this in context, fewer than 20 complete human genomes have been sequenced in the world to date.

Complete Genomics also is developing sophisticated analysis tools that will help its customers interpret their data. Such tools will allow them to browse data, assemble genomes, annotate and compare genomes, and run association studies.

Growth Potential

"Complete Genomics is a game-changing company with incredible growth potential. Not only has it developed a sequencing technology that will enable it to sell complete human genomes for $5,000, it has also built a scalable services model to accommodate pent-up industry and research demand. And this is just the beginning. Complete Genomics' technology costs will decrease further as the volume of genomes it sequences goes up, providing a durable competitive advantage," said Dr. Alex Barkas, managing director of Prospect Venture Partn
'/>"/>

SOURCE Complete Genomics Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. SyntheMed Completes $4.0 Million Equity Placement
2. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
3. SAFC Pharma Completes Large-Scale API Manufacturing Expansion in Ireland
4. Novagali Pharma Completes a EUR15 Million Fund Raising
5. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
6. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
7. Roche completes acquisition of ARIUS
8. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
9. Nanoscience Instruments, Inc. Announces Distribution of Nascatec's Complete Line of Unique AFM Probes and Sensors
10. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
11. Friends of the Earth Report on Biofuel Production Offers Incomplete, Outdated and Inaccurate Picture, According to Brazilian Sugarcane Industry Association